The 1-min sit-to-stand test—A simple functional capacity test in cystic fibrosis? by Radtke, Thomas et al.
Zurich Open Repository and
Archive
University of Zurich
Main Library
Strickhofstrasse 39
CH-8057 Zurich
www.zora.uzh.ch
Year: 2016
The 1-min sit-to-stand test—A simple functional capacity test in cystic
fibrosis?
Radtke, Thomas; Puhan, Milo A; Hebestreit, Helge; Kriemler, Susi
DOI: 10.1016/j.jcf.2015.08.006
Posted at the Zurich Open Repository and Archive, University of Zurich
ZORA URL: http://doi.org/10.5167/uzh-117068
Accepted Version
 
 
Originally published at:
Radtke, Thomas; Puhan, Milo A; Hebestreit, Helge; Kriemler, Susi (2016). The 1-min sit-to-stand test—
A simple functional capacity test in cystic fibrosis? Journal of Cystic Fibrosis, 15(2):223-226. DOI:
10.1016/j.jcf.2015.08.006
	   1 
The 1-min sit-to-stand test – a simple functional capacity test in cystic fibrosis? 
Thomas Radtke1, Milo A. Puhan1, Helge Hebestreit2, Susi Kriemler1 
 
1 Epidemiology, Biostatistics and Prevention Institute, University of Zürich, Zurich, 
Switzerland 
2   Paediatric Department, Julius-Maximilians University Würzburg, Germany 
 
Online supplementary material 
 
Methods 
Participants 
Patients with CF who participated in a three-week pulmonary rehabilitation in Gran Canaria 
in November/December 2014 were included. All participants were required to send in a 
sputum sample and a precise personal history prior to pulmonary rehabilitation. Patients with 
Burkholderia cepacia complex and methicillin-resistant Staphylococcus aureus (MRSA) 
without Pseudomonas infection were excluded. The rehabilitation program took part in a large 
hotel where each patient had his/her own room. The program included a daily 30-min outdoor 
supervised group exercise session including gymnastics and strengthening exercises in the 
morning and a second supervised exercise session (e.g. tennis, volleyball) in the afternoon 
lasting 60-90 min. Furthermore, participants received daily individual chest physiotherapy in 
a segregated fashion (mainly airway clearance supervised by an experienced physiotherapist) 
for 45 min. Utmost precautions were taken to prevent cross-infection, including proper 
disinfection of rooms and materials, hand disinfection, no direct body contact, and diagnostic 
and therapeutic sequence according to resistance of pulmonary pathogens [1]. All participants 
provided written informed consent. Ethical approval was obtained from the cantonal ethical 
committee of Zurich, Switzerland. 
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Pulmonary function testing 
Spirometry was performed at the beginning and the end of the pulmonary rehabilitation in 
sitting position using a commercially available system (METAMAX® 3B, Cortex Biophysik 
GmbH, Leipzig Germany) according to ATS/ERS standards [2]. Percent predicted values 
were calculated for forced expiratory volume in 1s (FEV1) and forced vital capacity (FVC) 
based on equations recently published by Quanjer et al [3]. 
 
1-Minute sit-to-stand test 
The 1-min STS test was performed on a conventional chair without armrest (height of the 
seat: 46-48 cm to reach a knee angle of a visually determined 90° angle). Each STS test 
consisted of a 1-min rest phase with the participant sitting quietly on a chair followed by the 
1-min STS exercise and a 3-min recovery phase with the participant sitting on the chair. 
During the active phase, the participants were instructed to stand-up and sit-down as often as 
possible at a self-chosen speed over one minute and they were allowed to stop anytime during 
the test. When standing up, the legs had to be fully straight and when sitting down, the 
buttock had to have clear contact with the chair. Heart rate (Polar® chest belt) and SaO2 
(Nonin® Xpod® PureSAT®, (METAMAX® 3B, Cortex Biophysik GmbH, Leipzig Germany) 
were continuously monitored during the test. At the end of the 1-min STS exercise, ratings of 
perceived exertion and dyspnea were evaluated by means of a 0-10 Borg scale. An illustration 
of a STS test with additional measurement of expired gases in a 27 year-old male patient with 
severe CF lung disease (FEV1 38% predicted) is presented in Figure S1. 
All participants performed five STS tests during the pulmonary rehabilitation program. The 
first test (STS0) on day 2 of the program was considered a practice trial to familarise the 
participants with the testing procedures. The second STS test (STS1) on day 3 was used as 
baseline test. The last three STS tests (STS2a-2c) were performed at the end of the 
rehabilitation program on day 17 and day 19 for the purpose of testing test-retest reliability 
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[4]. For logistical reasons (CPET had to be performed on all subjects during the same days), 
seven participants performed two STS tests (STS2a,b) at day 17 and one test on day 19 (STS2c) 
of the pulmonary rehabilitation program and seven participants performed one STS test 
(STS2a) at day 17 and two STS tests (STS2b,c) on day 19. A 15-minute rest was provided in-
between the two repetitive STS tests. The sequence of testing was based on “malignancy” of 
pulmonary pathogens, but participants abstained from heavy exercise on the testing day and 
the physiotherapy session was always performed afterwards.  
 
Cardiopulmonary exercise testing 
CPET was performed after the STS test at the beginning (day 2 or day 3) and at the end (day 
17 or 19) of the pulmonary rehabilitation program on a cycle ergometer (Lode Corival 
906900, Lode BV, Groningen, Netherlands) using the Godfrey protocol [5]. The metabolic 
cart (METAMAX® 3B, Cortex Biophysik GmbH, Leipzig Germany) was calibrated with 
gases of known standard concentrations at each testing day. Heart rate was measured with a 
chest belt (Polar®) and oxygen saturation (SaO2) was measured at the earlobe using a Nonin® 
Xpod® PureSAT® sensor both connected with the metabolic cart. Ratings of perceived 
exertion and dyspnea were evaluated at peak exercise by means of a 0-10 Borg scale [6]. 
Three of the following criteria had to be fulfilled to ensure the test was maximal: 1) plateau in 
VO2 despite an increase in workrate; 2) peak heart rate over 85% of predicted [7], respiratory 
exchange ratio (RER) > 1.05, 4) peak ventilation exceeded predicted maximum voluntary 
ventilation (calculated as FEV1 x 35) and 5) subjective impression of the supervisor. Data for 
peakVO2 and maximum power are presented as % predicted values [8]. 
 
Health related quality of life 
Health-related quality of life (HRQoL) was assessed with the revised adolescent and adult 
version of the German Cystic Fibrosis Questionnaire (CFQ-R) at the beginning and end of the 
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pulmonary rehabilitation [9]. The CFQ-R is a self-administered and disease-specific health-
related questionnaire with five generic scales (physical functioning, vitality, emotional state, 
social limitations, role limitations), four disease-specific scales (feelings of embarrassment 
about symptoms, eating disturbance, body image, treatment burden), one scale on the 
subjective general health perception, and three scales assessing respiratory symptoms, 
digestive symptoms and weight problems. For each scale, the score is given on a 0- to 100-
point scale with higher scores denoting higher HRQoL. We limited our analysis to the scales 
physical functioning and respiratory symptoms, as they were considered responsive to a 
rehabilitation program. The respiratory symptom scale served as anchor to estimate the 
minimal important difference (MID) for the STS [10]. 
 
The Feeling Thermometer 
The Feeling Thermometer is a modified visual analogue scale in form of a thermometer. The 
instrument has marked intervals from 0 (worst health state = dead) to 100 (perfect health) and 
has been used in respiratory research [11, 12]. 
 
Statistical analysis 
Data are presented as median (interquartile range, IQR) or means and standard deviations. All 
statistical analyses were performed with the statistical software package SPSS version 22 
(IBM Corp. Armont, NY, USA). The significance level was set at P<0.05. 
 
Learning effect 
To document a possible learning effect for STS test performance, we analysed differences in 
the median number of repetitions between the first two STS tests (STS0 and STS1) using a 
non-parametric Wilcoxon signed-rank test.  
 
	   5 
Test-retest reliability 
The median number of repetitions between the three reliability STS tests (STS2a-2c) were 
analysed with the non-parametric Friedman Test. Precision of STS test repetitions and 
measured variables during the STS tests (heart rate, SaO2, exertion and dyspnea) were 
quantified by the intra-individual standard deviations (SDwithin subjects) calculated by the root-
mean-square (RMS) method and the coefficient of variation (CV/SDwithin subjects /overall mean) 
[4]. For three-point measurements at least 14 participants (51 exams) were needed to obtain 
valid precision errors using the RMS method [4]. Agreement between the three reliability STS 
tests (STS2a-2c) was investigated by the method of Bland and Altman [13]. We calculated 
intraclass correlation coefficients (ICC’s) for the STS tests to estimate reliability using a two-
way random model.  
 
Construct validity 
To determine construct validity, correlations between STS test repetitions (mean number of 
STS test repetitions from STS2a-2c) and peakVO2, pulmonary function, patient-reported health 
status and HRQoL (post rehabilitation values) were analysed with linear regression analysis.  
 
Minimal important difference 
To estimate the MID for the STS test, we used anchor-based and distributional methods [14]. 
The previously estimated MID of the respiratory symptoms scale (change of 4 units in stable 
CF patients) from the CFQ-R questionnaire was used as anchor to estimate the MID of the 
STS test [10]. Correlations between changes in STS test performance and the respiratory 
symptom scale were estimated with linear regression analysis. We further used a 
distributional method (0.5 SD) to estimate the MID, where the SD of the baseline test (STS1) 
is multiplied by 0.5.  
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Responsiveness to pulmonary rehabilitation 
We calculated Cohen’s effect size to evaluate changes in outcome variables after pulmonary 
rehabilitation. 
 
Results 
Study population 
Sixteen participants with CF took part in the pulmonary rehabilitation and performed all tests. 
Of those, data from two participants were excluded from the final analysis due to an 
unexpected death of a family member that reduced rehabilitation time and affected HRQoL 
assessments.  
 
Sit-to stand test 
Figure S1 shows an illustration of a STS test with online gas analysis.  
Figure S1. Illustration of a sit-to-stand (STS) test with measurement of expired gases in a 27-
year old patient with severe cystic fibrosis lung disease. Data were recorded breath-by-breath 
but shown as 10 s averages. The total test duration was 7 minutes: 3 min rest, 1-min STS test 
and 3 min recovery. The black box between 3 and 4 min indicates the 1-min STS exercise 
period. V’O2, oxygen consumption; V’CO2, carbon dioxide production; RER, respiratory 
exchange ratio; SaO2, oxygen saturation; RR, respiratory rate; VT, tidal volume; V’E, minute 
ventilation. Borg dyspnoea score was 9 after completion of the 1-minute exercise. Compared 
to a maximal cardiopulmonary exercise test using the Godfrey cycle protocol V’O2 at the end 
of the 1 min STS test reached 56%, V’CO2 46%, heart rate 84%; V’E 61%; VT 61%; RR 
100% and minimum SaO2 96%. 
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Test-retest reliability  
Table S1: Reliability characteristics of sit-to-stand test parameters. Data are from three STS 
tests at the end of a rehabilitation program. 
Parameter Median (IQR) Mean ± SD SDwithin 
subjects 
CV, % ICC 
 
STS2a 
 
65.0 (55.8, 67.0) 
 
62.4 ± 8.2 
 
- 
 
- 
 
- 
 
STS2b 
 
67.0 (57.0, 70.5) 
 
64.7 ± 8.4 
 
- 
 
- 
 
- 
 
STS2c 
 
66.5 (59.8, 72.5) 
 
66.1 ± 9.2 
 
- 
 
- 
 
- 
Mean number of 
repetitions from 
STS2a-c (N)  
67.3 (57.5, 70.3) 64.5 ± 8.5 2.87 3.84 0.984 
Peak heart rate 
(beats.min-1)* 
151.2 (145.3, 
159.3) 
151.2 ± 
10.8 
5.84 3.86 0.913 
Minimum SaO2 
(%)* 
93.0 (85.7, 94.4) 90.9 ± 4.7 1.39 1.53 0.978 
Dyspnea (0-10 
scale) * 
2.8 (2.2, 7.1) 4.3 ± 2.8 1.28 60.09 0.933 
Borg exertion (0-10 
scale)* 
6.3 (3.7, 8.2) 6.1 ± 2.4 0.97 16.37 0.950 
Data are based on three sit-to-stand tests. CV, coefficient of variation (calculated by root-
mean-square method); ICC, intraclass correlation coefficient; IQR, interquartile range; SaO2, 
transcutaneous arterial oxygen saturation; SD, standard deviation. * denotes variables with 
skewed distribution.  
 
Figure S2 
Figure 2S shows Bland-Altman plots for comparisons between the three reliability STS tests 
(STS2a vs. STS2b and STS2b vs. STS2c). 
 
